Incyte (INCY) Non-cash Items (2011 - 2021)
Incyte (INCY) reported Non-cash Items of $13.5 million for Q4 2021, down 84.36% on a YoY basis from $86.3 million in Q4 2020, and down 84.36% quarter-over-quarter from $86.3 million in Q4 2020.
Incyte (INCY) Non-cash Items (2011 - 2021) Analysis & Trends
Incyte has reported Non-cash Items for 10 years, with the latest figure at $13.5 million in Q4 2021.
- For the quarter ending Q4 2021, Non-cash Items fell 84.36% year-over-year to $13.5 million; the trailing twelve-month figure through Dec 2021 stood at $13.5 million (down 84.36% YoY), and the FY2021 full-year result was $13.5 million, down 84.36% from the prior year.
- Non-cash Items for Q4 2021 stood at $13.5 million, down from $86.3 million in the prior quarter.
- The five-year high for Non-cash Items was $362.8 million in Q4 2017, with the low at $13.5 million in Q4 2021.
- Historically, Non-cash Items has averaged $156.3 million across 4 years, with a median of $124.4 million in 2019.
- Annual changes were most pronounced in 2017 — Non-cash Items slumped 39.48% — and 2021, when it slumped 84.36%.
- Incyte's Non-cash Items stood at $362.8 million in 2017, then sank by 55.21% to $162.5 million in 2019, then sank by 46.89% to $86.3 million in 2020, then sank by 84.36% to $13.5 million in 2021.
- The last three Non-cash Items figures came in at $13.5 million (Q4 2021), $86.3 million (Q4 2020), and $162.5 million (Q4 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Incyte | 19.62 Bn | 15.60 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 13.50 Mn |
| Dec 31, 2021 | 13.50 Mn |
| Dec 31, 2020 | 86.30 Mn |
| Dec 31, 2020 | 86.30 Mn |
| Dec 31, 2019 | 162.50 Mn |
| Dec 31, 2019 | 162.50 Mn |
| Dec 31, 2017 | 362.80 Mn |
| Dec 31, 2017 | 362.80 Mn |
| Dec 31, 2016 | 599.50 Mn |
| Dec 31, 2016 | 599.50 Mn |
| Dec 31, 2015 | 828.90 Mn |
| Dec 31, 2015 | 828.90 Mn |
| Dec 31, 2014 | 749.60 Mn |
| Dec 31, 2014 | 749.60 Mn |
| Sep 30, 2014 | 11.42 Mn |
| Sep 30, 2014 | 11.42 Mn |
| Jun 30, 2014 | 10.92 Mn |
| Jun 30, 2014 | 10.92 Mn |
| Jun 30, 2013 | 14.84 Mn |
| Jun 30, 2013 | 14.84 Mn |